key: cord-0819090-19y6ljda
authors: Berenger, Byron M.; Conly, John M.; Fonseca, Kevin; Hu, Jia; Louie, Thomas; Schneider, Angela R.; Singh, Takshveer; Stokes, William; Ward, Linda; Zelyas, Nathan
title: Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2
date: 2020-11-04
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.10.035
sha: 8e4678a3aebcfce53812c0cca18fc49de3b181ad
doc_id: 819090
cord_uid: 19y6ljda

nan

During the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Co-V-2) pandemic we 26 have encountered unprecedented testing volumes and the constant supply chain disruptions 27 including swabs. These challenges could be somewhat alleviated by using saliva as a sample 28 type because it is easy to collect, does not use swabs, and is amenable to high-volume collection. 29

In this journal, Skolimowska et al. argued that saliva is not an appropriate sample type for 30 SARS-Cov-2 PCR [1] , but others have shown that crude saliva can be as sensitive as a 31 nasopharyngeal (NP) swab [2] . However, crude saliva is not amenable to high-volume and 32 automated processing because saliva can be difficult to pipette due to its viscosity [2] and in our 33 experience, it can congeal shortly after collection. Furthermore, processing crude saliva requires 34 many manual manipulations including the addition of media at the laboratory, careful mixing, 35 adding proteinase K, and/or centrifugation steps [1] [2] [3] . Crude saliva added to universal/viral 36 transport media (VTM/UTM) at the point of collection is amenable to high-volume automated 37 processing because the saliva arrives to the lab suspended in liquid form. An added benefit of 38 UTM is its ubiquitous use and the extensive experience with this medium for molecular and 39 culture-based diagnostics of viruses and other pathogens. Most assays and lab equipment are 40 validated using this medium and have regulatory agency approval for specimens collected in 41

We initially investigated saliva collection for SARS-CoV-2 diagnosis via a saline gargle and spit 43 method but found it to be substantially inferior to a NP swab. In this journal, Pasomsub et al. It is noteworthy that our UTM test group were primarily outpatients as opposed to all in 84 Pasomsub et al.) whereas 59% were hospitalized in our gargle group as opposed to 100% in 85 Jamal et al. [6] . Hospitalized patients may have altered saliva composition and production due to 86 co-morbidities and/or multiple medications lowering saliva production and altering saliva 87 composition [7]. Controlling for variation in saliva production by collecting specific volumes 88 may improve the UTM method sensitivity, which is not possible with the gargle method. An 89 additional factor that may have contributed to the differences observed between groups is the 90 mean time from symptom onset to study sampling, which was longer in our gargle test group and 91 SARS-CoV-2 pandemic. However, due to the utility of UTM for the detection of other 94 respiratory viruses and the benefits for the detection of SARS-CoV-2 we demonstrated herein 95 ensuring secure production and a supply chain of UTM is needed for this current pandemic and 96 for respiratory virus seasons. 97

Although collection of NP swab alone (or with an OP swab) and saliva in UTM may provide 98 higher sensitivity than saliva alone, saliva in UTM offers many advantages over a NP swab 99 because it is non-invasive, convenient (especially for children), involves minimal labour and 100 lends itself well to mass screening programs. 101 

Non-invasive 128 saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with 129 low prevalence

Mass screening of 134 asymptomatic persons for SARS-CoV-2 using saliva

Saliva sample as a non-invasive specimen for the diagnosis of 138 coronavirus disease 2019: a cross-sectional study

Development and 141 validation of reverse transcriptase-PCR assays for the testing of SARS-CoV-2

Sensitivity 144 of nasopharyngeal swabs and saliva for the detection of Severe Acute Respiratory 145

Syndrome Coronavirus 2

Interventions for the 147 management of dry mouth: topical therapies. Cochrane Database Syst Rev